TRNS vs. CAMT, TXG, ALNT, EYPT, LAB, CTKB, SENS, QSI, AEHR, and MASS
Should you be buying Transcat stock or one of its competitors? The main competitors of Transcat include Camtek (CAMT), 10x Genomics (TXG), Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Aehr Test Systems (AEHR), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.
Transcat vs. Its Competitors
Camtek (NASDAQ:CAMT) and Transcat (NASDAQ:TRNS) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.
Camtek received 351 more outperform votes than Transcat when rated by MarketBeat users. Likewise, 71.09% of users gave Camtek an outperform vote while only 65.84% of users gave Transcat an outperform vote.
41.9% of Camtek shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 79.4% of Camtek shares are owned by insiders. Comparatively, 2.3% of Transcat shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Camtek has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Comparatively, Transcat has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500.
Camtek has a net margin of 27.61% compared to Transcat's net margin of 6.22%. Camtek's return on equity of 24.99% beat Transcat's return on equity.
Camtek has higher revenue and earnings than Transcat. Camtek is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
In the previous week, Transcat had 3 more articles in the media than Camtek. MarketBeat recorded 12 mentions for Transcat and 9 mentions for Camtek. Camtek's average media sentiment score of 1.18 beat Transcat's score of 0.15 indicating that Camtek is being referred to more favorably in the media.
Camtek presently has a consensus price target of $90.78, indicating a potential upside of 19.63%. Transcat has a consensus price target of $114.00, indicating a potential upside of 50.87%. Given Transcat's higher possible upside, analysts plainly believe Transcat is more favorable than Camtek.
Summary
Camtek beats Transcat on 15 of the 19 factors compared between the two stocks.
Get Transcat News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TRNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Transcat Competitors List
Related Companies and Tools
This page (NASDAQ:TRNS) was last updated on 6/12/2025 by MarketBeat.com Staff
